Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at McMaster University have identified a molecule that may help turn the tide — ...

Metabolic diseases have reached epidemic proportions in our society, driven by a sedentary lifestyle coupled with circadian ...

An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important role in shaping the ...

First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic inflammatory diseasesEvolution of Nucleome's non-coding genetics ...

Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug (IND) clearance from the U.S. FDA, marking another major expansion to the co ...

Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...